Cigna Group (NYSE:CI) Stock Price Expected to Rise, Truist Financial Analyst Says

Cigna Group (NYSE:CIGet Free Report) had its target price increased by investment analysts at Truist Financial from $320.00 to $350.00 in a report issued on Tuesday, MarketBeat.com reports. The brokerage currently has a “buy” rating on the health services provider’s stock. Truist Financial’s price objective indicates a potential upside of 20.59% from the stock’s current price.

A number of other equities analysts also recently commented on the stock. TD Cowen boosted their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Leerink Partners boosted their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Cantor Fitzgerald dropped their price objective on Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. Royal Bank Of Canada cut their target price on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Finally, Robert W. Baird decreased their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $330.63.

Read Our Latest Stock Report on Cigna Group

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $290.24 on Tuesday. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock’s fifty day moving average price is $278.52 and its 200-day moving average price is $283.99. The firm has a market cap of $77.53 billion, a P/E ratio of 13.09, a P/E/G ratio of 1.01 and a beta of 0.27. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period in the prior year, the business earned $6.64 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cigna Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CI. Solstein Capital LLC acquired a new position in shares of Cigna Group in the second quarter valued at about $29,000. Harbor Capital Advisors Inc. boosted its position in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares during the last quarter. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the 4th quarter worth approximately $25,000. Chilton Capital Management LLC purchased a new position in Cigna Group during the 2nd quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC lifted its stake in Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 52 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.